ClinicalTrials.gg
RecruitingNCT05972096DBT+ContextUpdated Aug 2, 2023

DBT Skills Expanded With Contextual Intervention for Long Lasting Symptoms in Borderline Personality Disorder

An interventional study of Combination DBT, self-compassion and contextual-based skills in Borderline Personality Disorders and BPD, sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-08-02.

Sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2023, 3 years 1 month ago, but the record still lists the study as recruiting.
  • Registered 1 year 4 months after the study started (first participant enrolled Mar 2022, registered Jul 2023).
  • Started Mar 2022; still recruiting 4 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in Borderline Personality Disorder with a site in Spain — 4 open to participants now, 4 under way, none of them phase 3. Borderline Personality Disorder · Spain.

Planned enrollment
13th of 18
60 · median 107
Started
2022
with 2 others
No phase
12 of 19
4 open now
Registered
17th of 19
by date
Lead sponsor
4 of 19
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Among the 19 studies in Borderline Personality Disorder with a site in Spain, this one is the 13th largest by planned enrollment of the 18 interventional ones that give a count, is one of 3 that started in 2022, is one of 12 with no phase, and was the 17th registered.

Borderline Personality Disorder

279 studies on the registry are indexed under Borderline Personality Disorder; 70 are open to participants now.

Browse Borderline Personality Disorder studies →

Open to participants now

4 of the 19 studies in Borderline Personality Disorder with a site in Spain are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 49 Borderline Personality Disorder studies recruiting now, 18 (37%) set no upper age limit and 30 (61%) stop at 75 or younger; 7 take children under 18; 11 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Borderline Personality Disorder with a site in Spain, or all of them as a file.
02

Study summary

Although borderline personality disorder (BPD) tend to the clinical remission in long-term follow-up studies, a significant subgroup of patients continues to present long lasting symptoms such as low mood, emptiness and persistent impairment in psychosocial adjustment. The prevalence of this subsample of individuals is considerably increasing last years. New interventions addressed to these individuals are need, the aim of this study is to evaluate the efficacy of a novel intervention combining dialectical behavioral therapy skills training with self-compassion and contextual-based skills for patients with long-lasting BPD.

Read the detailed description

Sixty individuals with BPD and long lasting symptoms that have been received previously dialectical-behavioral therapy skills training (DBT-ST) will be included in a randomized clinical trial. They will be randomly assigned to receive an add-on skills training intervention involving the combination of DBT-ST, self-compassion, and contextual-based skills for long lasting symptoms versus treatment as usual during 12-weeks. Patients will be evaluated pre and post intervention and 3-month follow-up. The outcome measures are well-being indicators and clinical variables.

03

Conditions studied

  • Borderline Personality Disorders
  • BPD

Keywords

  • borderline personality disorder
  • long-lasting symptoms
  • dialectical behavior therapy skills
  • contextual approach.
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults between 18 and 65 years of age
  • Primary diagnosis of BPD according to Diagnostic Statistical Manual IV criteria and by the structured interviews: Diagnosis Structured clinical interview for axis II personality disorders (SCID II; First et al. 1997) and Diagnostic Interview for Borderlines Revised (DIB-R)
  • Previous participation in DBT-ST intervention
  • Signed .

Exclusion criteria

Exclusion Criteria:

  • Presence of life-threatening behaviors in the last 12 months
  • PTSD or related symptoms
  • Diagnosis of drug-induced psychosis, organic brain syndrome, bipolar or psychotic disorder
  • Intellectual disability
  • Participation in any other psychotherapy treatment during the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Combination of DBT-ST, self-compassion, and contextual-based skills.

    Combination of DBT-ST, self-compassion, and contextual-based skills.

    Behavioral: Combination DBT, self-compassion and contextual-based skills

  • Placebo comparator
    Control Group

    Treatment as usual. Although these individuals did not receive any new specific psychotherapeutic intervention for BPD, they valued the higher frequency of psychiatric visits, attention in crisis, family care, and greater experience and sensitivity in the management of BPD.

    Behavioral: Combination DBT, self-compassion and contextual-based skills

Interventions

  • BehavioralCombination DBT, self-compassion and contextual-based skills

    Psychotherapy combination. Skills of DBT plus self-compassion and contextual skills

06

What researchers measure

Primary outcomes

  1. Pemberton Happiness Index (PHI)

    Happiness index (minimum 0- maximum 110) Higher scores better

    Time frame: 1 month

Secondary outcomes

  1. Borderline Symptoms List-23 (BSL-23)

    Symptoms of Borderline (minimum 0- maximum 92). Higher scores worse

    Time frame: 1 week

  2. Remission from Depression Questionnaire (RDQ)

    Depression (minimum 0- maximum 84). Higher scores worse

    Time frame: 1 week

  3. Self Compassion Scale Short Form (SCS-SF)

    Compassion scale (12 items, minimum 12- maximum 60). Higher scores worse

    Time frame: 1 month

  4. Forms of Self-Criticism/Self-Attacking and Self-Reassuring Scale (FSCRS)

    Self-criticism forms (14 items, minimum 0- maximum 56). Higher scores worse

    Time frame: 1 month

  5. Satisfaction with life scale (SWLS)

    Well being (5 items, minimum 5 - maximum 25). Higher scores better

    Time frame: 1 month

  6. Quality of life scale (WHO-QOL_BREF)

    Quality of life OMS (26 items, minimum 26- maximum 130). Higher scores better

    Time frame: 2 weeks

07

Study locations

1 of 1 sites recruiting
  • Juan Carlos Pascual Mateos
    Barcelona, 08041, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2022 (actual). Primary completion is estimated for Oct 2023, 19 months after the start.

Of 106 non-industry interventional studies with no phase under Borderline Personality Disorder, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 54. This study's planned 19 months is below that.

Counting every sponsor, half of 108 studies reached it within 35 months; a quarter within 24 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 17, 2023
First posted
Aug 2, 2023
StartActual
Mar 1, 2022
Primary completionEst.
Oct 1, 2023
CompletionEst.
Oct 1, 2023
Last update
Aug 2, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 2, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05972096
Responsible party
Sponsor
First posted
Aug 2, 2023
Start date
Mar 1, 2022
Primary completion
Oct 1, 2023 (estimated)
Completion
Oct 1, 2023 (estimated)
Last update
Aug 2, 2023

Study contacts

Juan Carlos Pascual, PhD
Contact
jpascual@santpau.cat
34935537840
Joaquim Soler, PhD
principal investigator · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion